Citations

Clear

3942 citation(s) found for "To, Van".

Plasma lipids and fatty acids in urbanized Bushmen, Hereros and Kavangos of Southern Africa (Namibia)
Tichelaar, H.Y., Benadé, A. J. S., O’Keefe, Stephen J. , Jooste, P. L., Swanevelder, Sonja , Staden, E. Van

Mayo Clinic

Lipids | November 29, 2006 | Volume: 27 | Issue: 9 | Pages: 729-732

10.1007/bf02536033 | PMID 1487973 Get It

AbstractThirty‐nine urbanized ethnic Namibian people comprising 21 Bushmen (semi‐urbanized), 7 Hereros and 11 Kavangos were assessed for plasma lipids and fatty acid (FA) composition. Total cholesterol and triacylglycerol concentrations were measured by enzymatic methods, and neutral lipid FA composition by gas‐liquid chromatography. The results demonstrated that while total cholesterol concentrations were not significantly different, significant differences in triacylglycerol concentrations (P<0.05) were seen between Bushmen and Kavangos. By comparing Bushmen with Hereros and Kavangos, significant differences between Bushmen and Kavangos were also observed in plasma triacylglycerol FA compositions, particularly 16∶0 (32.73%vs. 25.05%), 16∶1n−7 (7.00%vs. 5.06%), 18∶2n−6 (9.30%vs. 22.25%) and 20∶3n−6 (0.12%vs. 0.48%), while Kavangos had higher 20∶4n−6 levels than Hereros (1.44%vs. 2.00%). In plasma cholesteryl esters, Bushmen were significantly different from Kavangos in 16∶1n−7 (8.85%vs. 4.93%), 18∶1n−9 (32.06%vs. 23.07%) and 20∶4n−6 (6.91%vs. 10.00%). Significant differences were also observed between Bushmen and Hereros in 18∶0 (1.08%vs. 1.29%) and 18∶2n−6 (35.68%vs. 45.50%). The FA of Namibian groups were also compared with South African reference groups comprising urbanized whites and Xhosas and rural Vendas. The differences in blood lipid values can be explained primarily by excessive alcohol consumption. These results suggest that semi‐urbanized Bushmen have changed their diets under urbanized conditions which may increase their risk of coronary heart disease.
Glucose Management in Patients Undergoing Operation for Insulinoma Removal
Muir, Jesse J., Endres, S, Offord, Kenneth P., Heerden, Jonathan A. van, Tinker, John H.

Mayo Clinic

Anesthesiology | October 17, 2006 | Volume: 59 | Issue: 5 | Pages: 371-375

10.1097/00000542-198311000-00001 | PMID 6314850 Get It

Metabolism of Methoxyflurane
Dyke, Russell A. Van, Wood, Catherine L.

Mayo Clinic

Anesthesiology | October 13, 2006 | Volume: 39 | Issue: 6 | Pages: 613-618

10.1097/00000542-197312000-00011 Get It

Elevation of Plasma Bromide Levels in Patients Following Halothane Anesthesia
Tinker, John H., Dyke, Russell A. Van, Gandolfi, Andrea

Mayo Clinic

Anesthesiology | October 9, 2006 | Volume: 44 | Issue: 3 | Pages: 194-196

10.1097/00000542-197603000-00003 | PMID 1267884 Get It

Binding of Radioactivity from 14C-labeled Halothane in Isolated Perfused Rat Livers
Dyke, Russell A. Van, Wood, Catherine L.

Mayo Clinic

Anesthesiology | October 5, 2006 | Volume: 38 | Issue: 4 | Pages: 328-332

10.1097/00000542-197304000-00005 | PMID 4145288 Get It

Increased Fibroblast Growth Factor-Inducible 14 Expression Levels Promote Glioma Cell Invasion via Rac1 and Nuclear Factor-κB and Correlate with Poor Patient Outcome
Tran, Nhan L. , McDonough, Wendy S., Savitch, Benjamin A., Ensign, Shannon P. Fortin , Winkles, Jeffrey A. , Symons, Marc , Cunliffe, Heather E. , Hoelzinger, Dominique B. , Rennert, Jessica L., Burkly, Linda C. , Loftus, Joseph C. , Ensign, Shannon P. Fortin , Nakada, Mitsutoshi , Hostetter, Galen H. , Michaelson, Jennifer S. , Lipinski, Christopher A. , Mariani, Luigi , Berens, Michael E. , Tran, Nhan L

Mayo Clinic

Cancer Research | October 3, 2006 | Volume: 66 | Issue: 19 | Pages: 9535-9542

10.1158/0008-5472.can-06-0418 | PMID 17018610 Get It

Abstract Glial tumors progress to malignant grades by heightened proliferation and relentless dispersion throughout the central nervous system. Understanding genetic and biochemical processes that foster these behaviors is likely to reveal specific and effective targets for therapeutic intervention. Our current report shows that the fibroblast growth factor-inducible 14 (Fn14), a member of the tumor necrosis factor (TNF) receptor superfamily, is expressed at high levels in migrating glioma cells in vitro and invading glioma cells in vivo. Forced Fn14 overexpression stimulates glioma cell migration and invasion, and depletion of Rac1 by small interfering RNA inhibits this cellular response. Activation of Fn14 signaling by the ligand TNF-like weak inducer of apoptosis (TWEAK) stimulates migration and up-regulates expression of Fn14; this TWEAK effect requires Rac1 and nuclear factor-κB (NF-κB) activity. The Fn14 promoter region contains NF-κB binding sites, which mediate positive feedback causing sustained overexpression of Fn14 and enduring glioma cell invasion. Furthermore, Fn14 gene expression levels increase with glioma grade and inversely correlate with patient survival. These results show that the Fn14 cascade operates as a positive feedback mechanism for elevated and sustained Fn14 expression. Such a feedback loop argues for aggressive targeting of the Fn14 axis as a unique and specific driver of glioma malignant behavior. (Cancer Res 2006; 66(19): 9535-42)
The Effects of Volatile Anesthetics on Ca++ Mobilization in Rat Hepatocytes
Iaizzo, Paul A. , Seewald, Markus J., Powis, Garth , Dyke, Russell A. Van

Mayo Clinic

Anesthesiology | October 2, 2006 | Volume: 72 | Issue: 3 | Pages: 504-509

10.1097/00000542-199003000-00019 | PMID 2310032 Get It

Venomotor Changes Caused by Halothane Acting on the Sympathetic Nerves
Muldoon, Sheila M., Vanhoutte, Paul M. , Lorenz, Robert R. , Dyke, Russell A. Van

Mayo Clinic

Anesthesiology | September 28, 2006 | Volume: 43 | Issue: 1 | Pages: 41-47

10.1097/00000542-197507000-00006 | PMID 238434 Get It

Pheochromocytoma and Paraganglioma in Children: A Review of Medical and Surgical Management at a Tertiary Care Center
Pham, Tuan H., Moir, Christopher R. , Thompson, Geoffrey B. , Zarroug, Abdalla E., Hamner, Chad E. , Farley, David R. , Heerden, Jon van, Lteif, Aida, Young, William F.

Mayo Clinic

Pediatrics | September 1, 2006 | Volume: 118 | Issue: 3 | Pages: 1109-1117

10.1542/peds.2005-2299 | PMID 16951005 Get It

OBJECTIVE. The aim of this study was to review our institutional experience managing pheochromocytomas and paragangliomas in children.METHODS. A retrospective chart review of the Mayo Clinic database from 1975 to 2005 identified 30 patients &lt;18 years of age with histologically confirmed pheochromocytoma or paraganglioma.RESULTS. There were 12 patients with pheochromocytomas and 18 with paragangliomas. The most common presenting symptoms were hypertension (64%), palpitation (53%), headache (47%), and mass-related effects (30%). Nine patients (30%) had a genetic mutation or documented family history of pheochromocytoma or paraganglioma. Fourteen patients (47%) had malignant disease, whereas 16 (53%) had benign disease. Logistic analysis showed that statistically significant risk factors for malignancy were (1) paraganglioma, (2) apparently sporadic, as opposed to familial, pheochromocytoma or paraganglioma, and (3) tumor size of &gt;6 cm. Surgical resection was performed for 28 patients (93%), with perioperative mortality and major morbidity rates of 0% and 10%, respectively. Resection achieved symptomatic relief for 25 patients (83%). All patients with benign disease appeared cured after resection. For patients with malignant disease, the 5- and 10-year disease-specific survival rates were 78% and 31%, respectively, and the mean survival time was 157 ± 32 months.CONCLUSIONS. The incidence of malignant pheochromocytoma/paraganglioma was high in children (47%), particularly those with apparently sporadic disease, paraganglioma, and tumor diameters of &gt;6 cm. Patients with a known genetic mutation or familial pheochromocytoma/paraganglioma were more likely to achieve resection with negative microscopic margins and had improved disease-specific mortality rates. Surgical resection remains the treatment of choice for pheochromocytoma and paraganglioma.
Proteomic Analysis of Pharmacological Preconditioning
Arrell, D. Kent , Elliott, Steven T., Kane, Lesley A. , Guo, Yurong , Ko, Young Hee, Pedersen, Pete L., Robinson, John C. , Murata, Mitsushige , Murphy, Anne M. , Marbán, Eduardo , Eyk, Jennifer E. Van

Mayo Clinic

Circulation Research | September 1, 2006 | Volume: 99 | Issue: 7 | Pages: 706-714

10.1161/01.res.0000243995.74395.f8 | PMID 16946135 Get It

Ischemic preconditioning is characterized by resistance to ischemia reperfusion injury in response to previous short ischemic episodes, a protective effect that can be mimicked pharmacologically. The underlying mechanism of protection remains controversial and requires greater understanding before it can be fully exploited therapeutically. To investigate the overall effect of preconditioning on the myocardial proteome, isolated rabbit ventricular myocytes were treated with drugs known to induce preconditioning, adenosine or diazoxide (each at 100 μmol/L for 60 minutes). Their protein profiles were then compared with vehicle-treated controls (n=4 animals per treatment) using a multitiered 2D gel electrophoresis approach. Of 28 significantly altered protein spots, 19 nonredundant proteins were identified (5 spots remained unidentified). The majority of these proteins are involved in mitochondrial energetics, including subunits of tricarboxylic acid cycle enzymes and oxidative phosphorylation complexes. These changes were not indiscriminate, with only a small number of enzymes or complex subunits altered, indicating a very specific and targeted affect of these 2 preconditioning mimetics. Among the changes were shifts in the extent of posttranslational modification of 4 proteins. One of these, the adenosine-induced phosphorylation of the ATP synthase β subunit, was fully characterized with the identification of 5 novel phosphorylation sites. This proteomics approach provides an overall assessment of the cellular response to pharmacological treatment with adenosine and diazoxide and identifies a distinct subset of enzymes and protein complex subunit that may underlie the preconditioned phenotype.